β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
Recent nutritional epidemiological surveys showed that serum β-cryptoxanthin inversely associates with the risks for insulin resistance and liver dysfunction. Consumption of β-cryptoxanthin possibly prevents nonalcoholic steatohepatitis (NASH), which is suggested to be caused by insulin resistance a...
Enregistré dans:
Auteurs principaux: | Masuko Kobori, Yinhua Ni, Yumiko Takahashi, Natsumi Watanabe, Minoru Sugiura, Kazunori Ogawa, Mayumi Nagashimada, Shuichi Kaneko, Shigehiro Naito, Tsuguhito Ota |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/835e2199ff0e45d095e3c7ba0807db45 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Association between Equol Production Status and Nonalcoholic Steatohepatitis
par: Takemi Akahane, et autres
Publié: (2021) -
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
par: Tae Hyung Kim, et autres
Publié: (2021) -
The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
par: D. H. Ipsen, et autres
Publié: (2021) -
Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
par: Kawanaka M, et autres
Publié: (2013) -
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
par: Alia Hadefi, et autres
Publié: (2021)